A judge in Texas could decide to pull the abortion pill off the market nationwide because it kills unborn babies and is incredibly dangerous for women — killing women and leading to so many injuries that there is an emergency room crisis in America.
The Alliance Defending Freedom (ADF) sued the FDA in November on behalf of four medical organizations, arguing that the agency approved the drugs in 2000 without studying their safety thoroughly. The four doctors groups say the FDA ignored evidence that the drugs cause more complications than surgical abortions and ignored their potential physical impacts on adolescent girls. Reports indicate one woman died from the abortion pill recently.
U.S. District Court Judge Matthew Kacsmaryk, appointed by former President Donald Trump, is ruling in this case, and he could decide to pull the mifepristone abortion drug from the market entirely. Such a ruling would mean making of the deadly abortion drug would have to start the FDA approval process over and, even if the FDA were to re-approve the drug, it would take the abortion pill off the market for at least a year or two — likely longer. That would be hundreds of thousands of babies saved from abortions and thousands of women spared horrific medical and mental health injuries.
If Judge Kacsmaryk pulls the abortion pill, an appeal of his decision would land the case in the conservative-leaning Fifth Circuit Court of Appeals that would also potentially rule in favor of the doctors groups.
Abortion pills make up a massive segment of the abortion industry; the drugs account for 53% of abortions — making it so the positive impact on protecting women and unborn children is astounding. It would even prohibit sales of the abortion pill in blue states where abortion is legal, often up to birth. The drug works by starving the unborn baby to death and then expelling the dead baby’s body.
HELP LIFENEWS SAVE BABIES FROM ABORTION! Please help LifeNews.com with a donation!
ADF senior counsel Erik Baptist told CNA that unborn babies are not the only ones harmed by chemical abortion. Baptist said that at least 1 in 6 women experience severe medical complications because of using chemical abortion drugs.
“The regimen that the FDA has currently approved is inherently dangerous because it allows a woman to self-administer and induce labor and delivery, in an abortion context, in her home, in her bathroom, in her dorm room, in a hotel room without any medical supervision,” Baptist told CNA.
“It’s inherently going to create a situation where there’s going to be potential for life-threatening infections, severe hemorrhaging, and bleeding … Therefore, it’s an inherently dangerous drug,” he said.
“This case is focused on protecting the health, welfare, and safety of women and girls who take chemical abortions because the FDA failed to follow the science and follow the law when approving and taking away basic protections for women and girls who do take these drugs,” Baptist said.
Doctors say the abortion drug is very dangerous for women and pulling it from the market is a good thing.
Dr. Ingrid Skop, an OB-GYN and director of Medical Affairs at the Charlotte Lozier Institute, told CNA that “chemical abortion pills are far more dangerous than surgical abortion. They are far more dangerous than the abortion industry has told the American public.”
“Most of the studies to get published about abortion are published by researchers associated with the abortion industry. And they ignore the known fact that we cannot do a reference linkage study to determine all the complications,” Skop explained. “So, when they report complications, they’re only reporting complications they know about. But the reality is women who have complications often do not return to the abortion provider because they’re surprised to have a complication because they’ve been told that there are hardly ever any complications.”
The drug mifepristone, typically used with a second drug, misoprostol, now is used for more than half of all abortions in the U.S. every year, or nearly half a million unborn babies, according to the Guttmacher Institute.
The FDA has linked mifepristone to at least 28 women’s deaths and 4,000 serious complications between 2000 and 2018. However, under President Barack Obama, the FDA stopped requiring that non-fatal complications from mifepristone be reported. So the numbers almost certainly are much higher.
Studies indicate the risks are more common than what abortion activists often claim, with as many as one in 17 women requiring hospital treatment. A recent study by the Charlotte Lozier Institute found that the rate of abortion-related emergency room visits by women taking the abortion drug increased more than 500 percent between 2002 and 2015.
Another new study from the University of Toronto, “Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion,” published in the Annals of Internal Medicine, found that one in ten women who took the abortion pill had to go to the emergency room, according to Pregnancy Help News.
